Advanced pulmonary sarcoidosis (APS) occurs in approximately 5% of sarcoidosis patients, and it accounts for most of the mortality, morbidity, and healthcare use. New and emerging advances can aid clinicians in managing the complications and pathophysiologic processes of APS. These include the use of inflammatory markers, new insights into sarcoidosis-associated pulmonary fibrosis and pulmonary hypertension, infectious complications, and lung transplantation. APS would be presented with a focus on gaps in...
Schedule: Live Sessions
Preview the Sessions That Took Place Live at CHEST 2020
All live session recordings are now available for CHEST 2020 registrants through the “Live Sessions” section of CHEST 2020 lobby.
Please note: This agenda only shows the live CHEST 2020 sessions.
View the CHEST 2020 On Demand sessions.
All original research presentation content for CHEST 2020 is embargoed until October 12.
The CHEST 2020 schedule is subject to change.